MedTrace Logo

PBMC Donation in UCAR-T Cells

NCT04091906 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-09-17

No results posted yet for this study

Summary

Peripheral blood mononuclear cell donation protocol for tumor immunotherapy study of UCAR-T cells

Conditions

  • Peripheral Blood Mononuclear Cell Donation

Interventions

DEVICE

Peripheral blood mononuclear cell apheresis

Peripheral blood mononuclear cell donation for tumor immunotherapy study of UCAR-T cells

Sponsors & Collaborators

  • Nanjing Bioheng Biotech Co., Ltd.

    collaborator INDUSTRY

  • The First Affiliated Hospital with Nanjing Medical University

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2020-03-31
Completion
2020-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04091906 on ClinicalTrials.gov